Inflammatix Inc
UnclaimedIn-Vitro Diagnostic Substance ManufacturingSunnyvale, CA
Founded
2016
Primary NAICS
325413
CAGE code
7Q4D9
Federal awards
$3.1M
Overview
Inflammatix is developing rapid point-of-care diagnostic tests by reading the immune response aimed to help physicians better diagnose acute infections and sepsis.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Research and Development in Biotechnology (except Nanobiotechnology)In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Health and Human Services | $0 | 1 |
| 2025 | Department of Health and Human Services | -$1 | 1 |
| 2024 | Department of Health and Human Services | $0 | 3 |
| 2023 | Department of Health and Human Services | $2,352,124 | 3 |
| 2022 | Department of Health and Human Services | $749,999 | 4 |